Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 26171-23-3
Drug Levels and Effects
Summary of Use during Lactation
Because of the low levels of tolmetin in breastmilk and its short half-life, it is unlikely to adversely affect the breastfed infant. However, because there is no published experience with breastfeeding during tolmetin use, other agents may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Following a single 400 mg dose of tolmetin in a woman who was 2 months postpartum, peak milk levels occurred at 40 and 60 minutes after the dose in the right and left breasts, respectively, and averaged 160 mcg/L. The drug was undetectable (<30 mcg/L) in milk by 5 hours after the dose and its half-life in breastmilk was 1.54 hours.[1]
Using the peak milk level data, the estimated maximum intake of an exclusively breastfed infant would be 0.4% of the maternal weight-adjusted dosage.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Acetaminophen, Flurbiprofen, Ibuprofen, Indomethacin, Naproxen, Piroxicam
References
- 1.
- Sagraves R, Waller ES, Goehrs HR. Tolmetin in breast milk. Drug Intell Clin Pharm. 1985;19:55-6. Letter. [PubMed: 3967576]
Substance Identification
Substance Name
Tolmetin
CAS Registry Number
26171-23-3
Drug Class
- Breast Feeding
- Analgesic Agents
- Nonsteroidal Antiinflammatory Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Indomethacin.[Drugs and Lactation Database (...]Review Indomethacin.. Drugs and Lactation Database (LactMed®). 2006
- Review Nalidixic Acid.[Drugs and Lactation Database (...]Review Nalidixic Acid.. Drugs and Lactation Database (LactMed®). 2006
- Review Droperidol.[Drugs and Lactation Database (...]Review Droperidol.. Drugs and Lactation Database (LactMed®). 2006
- Review Etidronate.[Drugs and Lactation Database (...]Review Etidronate.. Drugs and Lactation Database (LactMed®). 2006
- Review Methazolamide.[Drugs and Lactation Database (...]Review Methazolamide.. Drugs and Lactation Database (LactMed®). 2006
- Tolmetin - Drugs and Lactation Database (LactMed®)Tolmetin - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...